|
|
Predictive factors for percutaneous nephrolithotomy bleeding risks |
U Phun Loo*( ),Chun Hou Yong,Guan Chou Teh
|
Urology Department, Sarawak General Hospital, Kuching, Malaysia |
|
|
Abstract Objective: This study aimed to identify predictive factors for percutaneous nephrolithotomy (PCNL) bleeding risks. With better risk stratification, bleeding in high-risk patient can be anticipated and facilitates early identification. Methods: A prospective observational study of PCNL performed at our institution was done. All adults with radio-opaque renal stones planned for PCNL were included except those with coagulopathy, planned for additional procedures. Factors including gender, co-morbidities, body mass index, stone burden, puncture site, tract dilatation size, operative position, surgeon's seniority, and operative duration were studied using stepwise multivariate regression analysis to identify the predictive factors associated with higher estimated hemoglobin (Hb) deficiency. Results: Overall, 4.86% patients (n=7) received packed cells transfusion. The mean estimated Hb deficiency was 1.3 (range 0-6.5) g/dL and the median was 1.0 g/dL. Stepwise multivariate regression analysis revealed that absence of hypertension (p=0.024), puncture site (p=0.027), and operative duration (p=0.023) were significantly associated with higher estimated Hb deficiency. However, the effect sizes are rather small with partial eta-squared of 0.037, 0.066, and 0.038, respectively. Observed power obtained was 0.621, 0.722, and 0.625, respectively. Other factors studied did not correlate with Hb difference. Conclusion: Hypertension, puncture site, and operative duration have significant impact on estimated Hb deficiency during PCNL. However, the effect size is rather small despite adequate study power obtained. Nonetheless, operative position (supine or prone), puncture number, or tract dilatation size did not correlate with Hb difference. The mainstay of reducing bleeding in PCNL is still meticulous operative technique. Our study findings also suggest that PCNL can be safely done by urology trainees under supervision in suitably selected patient, without increasing risk of bleeding.
|
Received: 04 July 2021
Available online: 20 January 2024
|
Corresponding Authors:
*E-mail address: uphun90@gmail.com (U.P. Loo).
|
|
|
Patient demographic and characteristic | Valuea | Hb, mean difference, g/dL | p-Value | Age, year | 56 (21-82) | NA | 0.181 | Gender | 0.79 | Female | 70 (48.6) | 1.279 | Male | 74 (51.4) | 1.228 | Ethnicity | 0.301 | Malay | 35 (24.3) | 1.054 | Ethic Chinese | 23 (16.0) | 1.387 | Iban | 63 (43.8) | 1.297 | Bidayuh | 13 (9.0) | 1.765 | Others | 10 (6.9) | 0.723 | Obesity | 0.414 | Yes | 48 (33.3) | 1.144 | No | 96 (66.7) | 1.307 | Hypertension | 0.027 | Yes | 92 (63.9) | 1.096 | No | 52 (36.1) | 1.531 | Diabetes | 0.279 | Yes | 48 (33.3) | 1.108 | No | 96 (66.7) | 1.325 | CKD | 0.505 | Stage 1 | 20 (13.9) | 0.885 | Stage 2 | 54 (37.5) | 1.300 | Stage 3 | 57 (39.6) | 1.330 | Stage 4 | 9 (6.2) | 1.478 | Stage 5 | 4 (2.8) | 0.850 | Pre-operative anemia | 0.120 | Yes | 39 (27.1) | 1.013 | No | 105 (72.9) | 1.342 |
|
Patient characteristics affecting post-PCNL estimated Hb difference by univariate analysis (n=144).
|
Clinical characteristic | Valuea | Hb, mean difference, g/dL | p-Value | Stone size, mm2 | 1155 (116-8300) | NA | 0.171 | Staghorn disease | 0.207 | Yes | 43 (29.9) | 1.435 | No | 101 (70.1) | 1.175 | Puncture number | 0.010 | 1 | 117 (81.2) | 1.137 | ≥2 | 27 (18.8) | 1.756 | Puncture site | 0.008 | Lower pole | 65 (45.1) | 1.223 | Mid pole | 43 (29.9) | 0.984 | Upper pole | 33 (22.9) | 1.500 | Renal pelvis | 3 (2.1) | 3.033 | Tract size, Fr | 0.085 | 16-20 | 25 (17.4) | 0.900 | 21-30 | 119 (82.6) | 1.327 | Operative position | 0.571 | Prone | 84 (58.3) | 1.300 | Supine | 60 (41.7) | 1.187 | Surgeon's seniority | 0.095 | Trainee under supervision | 45 (31.2) | 1.489 | Consultant | 99 (68.8) | 1.146 | Operative duration, min | 100 (30-385) | NA | 0.001 |
|
Clinical factors affecting post-PCNL estimated Hb difference by univariate analysis (n=144).
|
Factors | p-Value | Partial eta-squared | Observed power | Hypertension | 0.024 | 0.037 | 0.621 | Puncture number | 0.523 | 0.003 | 0.098 | Puncture site | 0.027 | 0.066 | 0.722 | Operative duration | 0.023 | 0.038 | 0.625 |
|
Factors affecting post-PCNL estimated Hb difference: outcomes of multivariate logistic regression analysis.
|
[1] |
Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, et al. Surgical management of stones: American Urological Association/Endourological Society guideline, part II. J Urol 2016; 196:1161-9.
doi: 10.1016/j.juro.2016.05.091
pmid: 27238615
|
[2] |
WHO Expert Consultation. Appropriate body mass index for Asian populations and its implication for policy and intervention strategies. Lancet 2004; 363:157-63.
doi: 10.1016/S0140-6736(03)15268-3
|
[3] |
Cappellini MD, Motta I. Anemia in clinical practice-definition and classification: does hemoglobin change with aging? Semin Hematol 2015; 52:261-9.
doi: 10.1053/j.seminhematol.2015.07.006
pmid: 26404438
|
[4] |
Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS Jr. AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 2005; 173:1991-2000.
doi: 10.1097/01.ju.0000161171.67806.2a
pmid: 15879803
|
[5] |
Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089-100.
doi: 10.1111/j.1523-1755.2005.00365.x
pmid: 15882252
|
[6] |
Tabachnick BG, Fidell LS. Using multivariate statistics. 6th ed. Boston: Pearson Education; 2013. p. 104-5.
|
[7] |
Said SH, Al Kadum Hassan MA, Ali RH, Aghaways I, Kakamad FH, Mohammad KQ. Percutaneous nephrolithotomy; alarming variables for postoperative bleeding. Arab J Urol 2017; 15:24-9.
doi: 10.1016/j.aju.2016.12.001
|
[8] |
El-Nahas AR, Shokeir AA, El-Assmy AM, Mohsen T, Shoma AM, Eraky I, et al. Post-percutaneous nephrolithotomy extensive hemorrhage: a study of risk factors. J Urol 2007; 177:576-9.
doi: 10.1016/j.juro.2006.09.048
pmid: 17222636
|
[9] |
Srivastava A, Singh KJ, Suri A, Dubey D, Kumar A, Kapoor R, et al. Vascular complications after percutaneous nephrolithotomy: are there any predictive factors? Urology 2005; 66:38-40.
doi: 10.1016/j.urology.2005.02.010
pmid: 15992882
|
[10] |
Thomas K, Smith NC, Hegarty N, Glass JM. The Guy’s stone score-grading the complexity of percutaneous nephrolithotomy procedures. Urology 2011; 78:277-81.
doi: 10.1016/j.urology.2010.12.026
pmid: 21333334
|
[11] |
Un S, Cakir V, Kara C, Turk H, Kose O, Balli O, et al. Risk factors for hemorrhage requiring embolization after percutaneous nephrolithotomy. Can Urol Assoc J 2015; 9:E594-8. https://doi.org/10.5489/cuaj.2803.
|
[12] |
Galek L, Darewicz B, Werel T, Darewicz J. Haemorrhagic complications of percutaneous lithotripsy: original methods of treatment. Int Urol Nephrol 2000; 32:231-3.
doi: 10.1023/a:1007126900772
pmid: 11229637
|
[13] |
Mousavi-Bahar SH, Mehrabi S, Moslemi MK. Percutaneous nephrolithotomy complications in 671 consecutive patients: a single-center experience. Urol J 2011; 8:271-6.
pmid: 22090044
|
[14] |
Tee ES, Yap RWK. Type 2 diabetes mellitus in Malaysia: current trends and risk factors. Eur J Clin Nutr 2017; 71:844-9.
doi: 10.1038/ejcn.2017.44
pmid: 28513624
|
[15] |
Ab Majid NL, Omar MA, Khoo YY, Mahadir Naidu B, Ling Miaw Yn J, Rodzlan Hasani WS, et al. Prevalence, awareness, treatment and control of hypertension in the Malaysian population: findings from the National Health and Morbidity Survey 2006-2015. J Hum Hypertens 2018; 32:617-24.
doi: 10.1038/s41371-018-0082-x
pmid: 29899376
|
[16] |
Akman T, Binbay M, Sari E, Yuruk E, Tepeler A, Akcay M, et al. Factors affecting bleeding during percutaneous nephrolithotomy: single surgeon experience. J Endourol 2011; 25: 327-33.
doi: 10.1089/end.2010.0302
pmid: 21214412
|
[17] |
Meng X, Bao J, Mi Q, Fang S. The analysis of risk factors for hemorrhage associated with minimally invasive percutaneous nephrolithotomy. Biomed Res Int 2019; 2019:8619460. https://doi.org/10.1155/2019/8619460.
|
[18] |
Arora AM, Pawar PW, Tamhankar AS, Sawant AS, Mundhe ST, Patil SR. Predictors for severe hemorrhage requiring angioembolization post percutaneous nephrolithotomy: a single-center experience over 3 years. Urol Ann 2019; 11:180-6.
doi: 10.4103/UA.UA_75_18
pmid: 31040605
|
[19] |
Kessaris DN, Bellman GC, Pardalidis NP, Smith AG. Management of hemorrhage after percutaneous renal surgery. J Urol 1995; 153:604-8.
doi: 10.1097/00005392-199503000-00011
pmid: 7861493
|
[20] |
Martin X, Murat FJ, Feitosa LC, Rouvie`re O, Lyonnet D, Gelet A, et al. Severe bleeding after nephrolithotomy: results of hyperselective embolization. Eur Urol 2000; 37:136-9.
doi: 10.1159/000020129
pmid: 10705189
|
[21] |
Ruhayel Y, Tepeler A, Dabestani S, MacLennan S, Pet?ík A, Sarica K, et al. Tract sizes in miniaturized percutaneous nephrolithotomy: a systematic review from the European Association of Urology Urolithiasis Guidelines Panel. Eur Urol 2017; 72:220-35.
doi: S0302-2838(17)30084-2
pmid: 28237786
|
[22] |
Cheng H, Clymer JW, Po-Han Chen B, Sadeghirad B, Ferko NC, Cameron CG, et al. Prolonged operative duration is associated with complications: a systematic review and meta-analysis. J Surg Res 2018; 229:134-44.
doi: S0022-4804(18)30187-2
pmid: 29936980
|
[23] |
Yamaguchi A, Skolarikos A, Buchholz NP, Chomón GB, Grasso M, Saba P, et al. Operating times and bleeding complications in percutaneous nephrolithotomy:a comparison of tract dilation methods in 5537 patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study. J Endourol 2011; 25:933-9.
|
[24] |
Falahatkar S, Moghaddam AA, Salehi M, Nikpour S, Esmaili F, Khaki N. Complete supine percutaneous nephrolithotripsy comparison with the prone standard technique. J Endourol 2008; 22:2513-7.
doi: 10.1089/end.2008.0463
pmid: 19046091
|
[25] |
Birowo P, Tendi W, Widyahening IS, Rasyid N, Atmoko W. Supine versus prone position in percutaneous nephrolithotomy: a systematic review and meta-analysis. F1000Res 2020; 9:231. https://doi.org/10.12688/f1000research.22940.3.
doi: 10.12688/f1000research.22940.1
pmid: 33014345
|
[26] |
Allen D, O’Brien T, Tiptaft R, Glass J. Defining the learning curve for percutaneous nephrolithotomy. J Endourol 2005; 19: 279-82.
pmid: 15865512
|
[1] |
Arman Tsaturyan, Angelis Peteinaris, Constantinos Adamou, Konstantinos Pagonis, Lusine Musheghyan, Anastasios Natsos, Theofanis Vrettos, Evangelos Liatsikos, Panagiotis Kallidonis. Percutaneous antegrade management of large proximal ureteral stones using non-papillary puncture[J]. Asian Journal of Urology, 2024, 11(1): 110-114. |
[2] |
Tsung Mou, Oluwateniola Brown, Yingxiao Hua, Melissa Simon, XinQi Dong, Kimberly Kenton, C. Emi Bretschneider. Gender differences of lower urinary tract symptoms in older Chinese Americans[J]. Asian Journal of Urology, 2023, 10(4): 526-533. |
[3] |
Zhao Wang, Kaixuan Li, Quan Zhu, Haozhen Li, Ziqiang Wu, Xuesong Liu, Zhengyan Tang. Incidence and risk factors of in-hospital venous thromboembolism in non-oncological urological inpatients: A single center experience[J]. Asian Journal of Urology, 2023, 10(4): 546-554. |
[4] |
Rasim Güzel,Ümit Yildirim,Kemal Sarica. Contemporary minimal invasive surgical management of stones in children[J]. Asian Journal of Urology, 2023, 10(3): 239-245. |
[5] |
Giorgio Mazzon,Simon Choong,Antonio Celia. Stone-scoring systems for predicting complications in percutaneous nephrolithotomy: A systematic review of the literature[J]. Asian Journal of Urology, 2023, 10(3): 226-238. |
[6] |
Wei Zhu,Zhicong Huang,Guohua Zeng. Miniaturization in percutaneous nephrolithotomy: What is new?[J]. Asian Journal of Urology, 2023, 10(3): 275-280. |
[7] |
Xiaowei Yang,Lynn Sayer,Sam Bassett,Sue Woodward. The prevalence, associated factors, and impact of urinary incontinence in pregnant and postpartum women in Nanjing, China: A cross-sectional study[J]. Asian Journal of Urology, 2023, 10(3): 337-343. |
[8] |
Qinghui Wu,Kesavan Esuvaranathan,Teck Kheng Lee,Soo Leong Foo,Jian Ping Chai,Edmund Chiong. A pilot clinical study of developing an External Assist Targeting Device for rapid and precise renal calyx access during percutaneous nephrolithotomy[J]. Asian Journal of Urology, 2023, 10(3): 364-371. |
[9] |
. Reliability of nephrolithometric nomograms in patients treated with minimally invasive percutaneous nephrolithotomy: A precision study[J]. Asian Journal of Urology, 2023, 10(1): 70-80. |
[10] |
Pankaj N. Maheshwari,Amandeep Arora,Mahesh S. Sane,Vivek Jadhao. Evaluating factors associated with the risk of hydrothorax following standard supracostal percutaneous nephrolithotomy[J]. Asian Journal of Urology, 2022, 9(3): 301-306. |
[11] |
Sujeet Poudyal. Current insights on haemorrhagic complications in percutaneous nephrolithotomy[J]. Asian Journal of Urology, 2022, 9(1): 81-93. |
[12] |
Yudhistira Pradnyan Kloping,Niwanda Yogiswara,Yusuf Azmi. The role of preoperative dutasteride in reducing bleeding during transurethral resection of the prostate: A systematic review and meta-analysis of randomized controlled trials[J]. Asian Journal of Urology, 2022, 9(1): 18-26. |
[13] |
Abhishek Gajendra Singh,Sundaram Palaniappan,Shrikant Jai,Gopal Tak,Arvind Ganpule,Ravindra Sabnis,Mahesh Desai. The clinical outcomes of laser with suction device in mini-percutaneous nephrolithotomy[J]. Asian Journal of Urology, 2022, 9(1): 63-68. |
[14] |
Dilip K. Mishra,Sonia Bhatt,Sundaram Palaniappan,Talamanchi V.K. Reddy,Vinothkumar Rajenthiran,Y.L. Sreeranga,Madhu S. Agrawal. Mini versus ultra-mini percutaneous nephrolithotomy in a paediatric population[J]. Asian Journal of Urology, 2022, 9(1): 75-80. |
[15] |
Yiwei Wang, Liheng Gao, Mingxi Xu, Wenfeng Li, Yuanshen Mao, Fujun Wang, Lu Wang, Jun Da, Zhong Wang. A novel spherical-headed fascial dilator is feasible for second-stage ultrasound guided percutaneous nephrolithotomy: A pilot study[J]. Asian Journal of Urology, 2021, 8(4): 424-429. |
|
|
|
|